Semaglutide Enclomaphine Citrate

Hestar Biotech was established in 2019. It is a national high-tech enterprise specializing in the research, development and production of peptides and related derivatives. It is also a governing unit of the Polypeptide Branch of the China Biochemical Pharmaceutical Industry Association.
The company currently has a peptide R&D center in Kunming, covering an area of more than 2,000 square meters, with two commercial peptide cooperative factories, several complete peptide production lines, several large-scale peptide synthesis equipment, imported HPLC analysis and preparation equipment, and Equipped with GMP standard clean laboratory. The company has currently passed the ISO9001:2015 quality management system certification.
The company has more than 40 employees, and its technical backbones have all been engaged in the peptide industry for about 15 years and can independently develop peptide projects. At present, the company has more than 40 mature pharmaceutical peptide products, and the annual output of peptides can reach more than 100kg. The total number of customized peptides has reached 20,000, and we can provide customers with one-stop services from R&D level (mg) to pilot scale to industrial production (kgs).